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InﬂammationThe oxidation of lipids has long been a topic of interest in biological and food sciences, and the fundamental
principles of non-enzymatic free radical attack on phospholipids are well established, although questions
about detail of the mechanisms remain. The number of end products that are formed following the initiation
of phospholipid peroxidation is large, and is continually growing as new structures of oxidized phospholipids
are elucidated. Common products are phospholipids with esteriﬁed isoprostane-like structures and chain-
shortened products containing hydroxy, carbonyl or carboxylic acid groups; the carbonyl-containing com-
pounds are reactive and readily form adducts with proteins and other biomolecules. Phospholipids can also
be attacked by reactive nitrogen and chlorine species, further expanding the range of products to nitrated
and chlorinated phospholipids. Key to understanding the mechanisms of oxidation is the development of ad-
vanced and sensitive technologies that enable structural elucidation. Tandem mass spectrometry has proved
invaluable in this respect and is generally the method of choice for structural work. A number of studies have
investigated whether individual oxidized phospholipid products occur in vivo, and mass spectrometry tech-
niques have been instrumental in detecting a variety of oxidation products in biological samples such as ath-
erosclerotic plaque material, brain tissue, intestinal tissue and plasma, although relatively few have achieved
an absolute quantitative analysis. The levels of oxidized phospholipids in vivo is a critical question, as there is
now substantial evidence that many of these compounds are bioactive and could contribute to pathology. The
challenges for the future will be to adopt lipidomic approaches to map the proﬁle of oxidized phospholipid
formation in different biological conditions, and relate this to their effects in vivo. This article is part of a Spe-
cial Issue entitled: Oxidized phospholipids—their properties and interactions with proteins.
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eactions for the formation of radical species from different oxidants present in aerobic
stems.
Oxidant systems Reactions
Fenton reaction (•OH) Fe (II)+H2O2→Fe (III)+HO•+HO−
Fe2++O2→ [Fe2+―O2↔Fe3+―O2•]→Fe3++O2•
Fe2++Fe2+―O2→Fe2+―O2―Fe2+→2 Fe2+―O
Radiation H2O→H2O*→H++ •OH
Pollution NO2+hv→NO+O
SOD (O2−) O2−•+O2−•+2H+→H2O2+O2
MPO H2O2+X−+H+→HOX+H2O
−OCl+H2O2→ 1O2+Cl−+H2O
NO synthases •NO+O2−•→ONOO−
ONOO−+H+→ONOOH
ONOOH→ •NO2+ •OH1. Introduction
1.1. Historical perspective on the oxidation of phospholipids
In the 21st century the role of lipid peroxidation in disease is still a
subject of considerable research, and within this area there is growing
interest in the roles of oxidized phospholipids, which have been
found in pathological conditions, often at raised levels compared to
normal physiology [1,2]. Studies with isolated cells and tissues have
demonstrated both pro-inﬂammatory and anti-inﬂammatory effects,
and have identiﬁed receptors and signalling pathways that contribute
to them [3–6]. The importance of oxidized phospholipids in biochemis-
try and pathophysiology is thus well accepted, although many ques-
tions about mechanisms and role in speciﬁc diseases remain
unanswered. The understanding that we have currently is built upon
knowledge of the types of oxidized phospholipids that can be formed,
which in turn depends on studies of the process of phospholipid oxida-
tion and peroxidation, together with constantly improving methodolo-
gies for product analysis.
Research on oxidation of phospholipids goes backmore than a centu-
ry, with very early studies by Thunberg in 1910 observing “respiration”
of phospholipid suspensions and noting that iron salts accelerated the
uptake of oxygen in tissues [7]. The term “oxidized phospholipids” was
reported for the ﬁrst time in 1939 by Frederik and Mary Bernheim, fol-
lowing the studies on the action of vanadium salts as catalysts in the ox-
idation of phospholipids from heart and brain tissues [8]. Mechanistic
studies of lipid peroxidation were ongoing from the 1940s; the free rad-
ical nature of the process was identiﬁed and a number of low molecular
weight fragmentation products, such asmalonaldehyde, pentanal and 4-
hydroxynonenal were identiﬁed [9], as will be described later in this ar-
ticle. However, until the late 1980s knowledge about the oxidized phos-
pholipid products was somewhat limited by the available methods of
structural analysis. The most structurally-informative method was gas
chromatography coupled with mass spectrometry detection (GC–MS),
but this required saponiﬁcation and derivatisation protocols in order to
generate volatile analytes, with resulting loss of information about the
original esteriﬁed structure, as well as the possibility of artefact genera-
tion through extensive sample manipulation. The introduction of fast
atom bombardment (FAB) and subsequently electrospray ionisation
(ESI) paved the way for analysis of less volatile biomolecules and re-
duced thermal degradation, thus enabling structural determination of
many oxidized phospholipids. At the end of 1980s, a phosphatidylcho-
line derivative that was a substrate for the platelet-activating acetylhy-
drolase enzyme found in human plasma was synthesized [10], and
found to be 1-palmitoyl-2-(5-oxo-pentanoyl)-3-glycero-PC (POVPC).
Later this compound and other structurally similar ones were found in
minimally oxidized low density lipoproteins (LDL) and atherosclerotic
plaques [11–13], leading to an association of oxPL with the process
of vascular dysfunction and atherosclerosis, thus prompting expan-
sion of this new ﬁeld of research. Full understanding of the role of
phospholipids and their oxidized counterparts is only recently
emerging with the development of user-friendly and robust mass
spectrometers that enable the complete mapping of phospholipid
species present in biological samples, and are attractive to a wider
range of researchers such as biologists, biochemists, pharmaceuti-
cals, and chemists.This article will describe the paradigm of non-enzymatic phospho-
lipid oxidation, and identify some aspects of the mechanisms that re-
main controversial or poorly understood. The wide range of
phospholipid oxidation products formed and their dependence on
the oxidizing system will be discussed, as well as the model systems
commonly used in such studies. The challenges of measuring and
quantifying oxidized phospholipids in vivo will be discussed, as well
as the limitations of existing methodology. The aim of this article is
to provide an introduction to other articles appearing in this issue
that will focus more deeply on individual aspects of the interactions
of oxidized phospholipids with proteins.
1.2. Types and sources of oxidants relevant to phospholipid oxidation
The oxidative modiﬁcations to phospholipids depend greatly on
the nature of the oxidant species, as this determines the mechanism
of the oxidative reactions. Radical species such as hydroxyl radicals
(•OH) and, to a lesser extent, superoxide radicals (O2−•) tend to be
regarded as more reactive and poorly selective, whereas many non-
radical species (e.g. hydrogen peroxide and HOCl) show more selec-
tive oxidation reactions with biomolecules and are able to diffuse
from their point of origin [14,15]. However, some non-radical
oxygen-containing species are highly oxidizing, such as ozone (O3),
singlet oxygen (1O2) and peroxynitrite (ONOO−), while nitric oxide
(•NO) can act both as a radical electron donor or oxidant [16–18].
The oxidants in aerobic systems can come from endogenous process-
es such as respiration, metabolism and phagocytosis [19], or from ex-
ogenous sources by inhalation of air pollutants and exposure to
radiation. In fact, many oxidants relevant to phospholipid oxidation
may derive from both exogenous and endogenous sources, such as
nitric oxide (generated by nitric oxide synthases but also found in ex-
haust fumes), transition metal ions, and ozone, which has been sug-
gested to be produced by neutrophils under certain conditions [18].
Superoxide radicals are also produced at low levels by NADPH oxi-
dases (NOX) and dual oxidases (DUOX) as part of cell signalling pro-
cesses [20].
Table 1 shows some of the reactions that form the radical species
capable of causing oxidation of phospholipids. Although superoxide
radicals are produced by a variety of endogenous reactions, they are
not particularly effective at causing hydrogen abstraction, andT
R
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species, notably hydroxyl radicals, are much more effective; they
react rapidly with various biological molecules, and have correspond-
ingly a low degree of selectivity in their reactions. Hydroxyl radicals
are formed mainly by one-electron redox reactions between H2O2
and pre-existing hydroperoxides with transition metal ions, although
radiation induced homolysis of water is another mechanism. Reac-
tions of ferrous (Fe2+) iron with hydrogen peroxide and oxygen
can generate ferryl (FeO2+) and perferryl species (FeO2+), which are
strong oxidants and have also been suggested to be capable of initiating
radical reactions [21]. Ozone, although not a radical, also leads to lipid
peroxidation through an addition reaction to yield an unstable species
that subsequently breaks down via homolytic cleavage reactions. Hypo-
halous acids (HOX, X−=Cl−, Br−, I−) and isothiocyanite (HOSCN) can
be produced by the enzyme myeloperoxidase, which is present at high
levels in neutrophils and at lesser levels in other polymorphonuclear
leukocytes. Eosinophil peroxidase is a similar enzymebutwith different
speciﬁcity [22]. The hypohalous acids are capable of 2-electron oxida-
tion of phospholipids, resulting in halogenated species such as chloro-
hydrins and α-chlorofatty aldehydes. Myeloperoxidase also catalyses
reactions to form the radical species nitrogen dioxide (•NO2) from hy-
drogen peroxide and nitrite [23]. Nitric oxide (•NO) is a relatively stable
and diffusible radical, but reacts rapidly with superoxide to form perox-
ynitrite (ONOO−). Peroxynitrite and its protonated form ONOOH are
not radical species, but can undergo a variety of one- and two-
electron reactions in biological environments, resulting in both oxidiz-
ing and nitrating reactions [17].
Thus the local concentration and nature of the oxidizing species,
as well as the presence of antioxidants, is important. For instance,
the low levels of [H2O2] in most cells (10−8–10−10 M) may limit
the potential for formation of hydroxyl radicals through the Fenton
reaction, and hence their role in mediating lipid peroxidation reac-
tions in phospholipids [21,24]. Instead, the higher ratio of [O2]/
[H2O2] found in cells suggests that oxidant systems, such as iron com-
plexes (ferryl/perferryl ions), may have more signiﬁcant roles in the
initiation of radical oxidation of unsaturated fatty acid moieties
when compared to hydroxyl radical [21]. On the other hand, in acidic
hypoxic environments the increased solubility of ferrous ions may ac-
count for the phospholipid modiﬁcation by the Fenton reaction with
pre-existing hydroperoxides (LOOH), formed by enzymatic systems
such as lipoxygenases (LOX) and cyclooxygenases (COX), although
at physiological pH most iron ions are in complexed form [25,26].2. Lipid peroxidation and other types of phospholipid oxidation
2.1. Basic concepts in peroxidation of polyunsaturated fatty acyl chains
Unsaturated fatty acids esteriﬁed to phospholipids are major tar-
gets for modiﬁcation under conditions of oxidative stress. In unsatu-
rated acyl chains, the hydrogen atoms on methylene groups
immediately adjacent to double bonds (allylic hydrogen atoms) ex-
hibit low carbon–hydrogen (C―H) bond energies, and those located
on methylenes between two double bonds (bis-allylic hydrogen
atoms) have even lower C―H bond energies, which allows them to
be readily abstracted by reactive radical species, leading to the forma-
tion of phospholipid radical species with the radical centred on the al-
lylic the carbon atom (Fig. 1). Comparatively, saturated fatty acid
chains such as palmitoyl and stearoyl are more resistant to oxidative
modiﬁcation as they do not have allylic hydrogen atoms [25]. Once
phospholipid carbon centred radicals (L•) are formed, they readily
react with molecular oxygen to form peroxyl radicals (LOO•). The ini-
tial hydrogen abstraction followed by addition of O2 corresponds to
the initiation phase of lipid peroxidation. In polyunsaturated fatty
acyl chains the addition of O2 molecules may occur several times on
a single acyl chain because of the presence of other (bis)allylichydrogen atoms or following rearrangement of a peroxyl radical to
a new carbon-centred radical.
Subsequent steps in the intermediate stage of the process lead to
the formation of further carbon- or oxygen-centred radicals. These in-
termediate peroxidation products, which include L• (alkyl), OL•
(epoxy alkyl), HOL• (hydroxy-alkyl), LO• (alkoxyl) and OLOO•
(epoxy-peroxyl) species, are responsible for perpetuating the radical
damage, as they can stabilise themselves by abstracting hydrogen
atoms from neighbouring molecules, thus leading to the formation
of new carbon-centred radicals on adjacent fatty acyl chains. This rep-
resents the propagation phase of lipid peroxidation, whereby a single
initial free radical attack generates damage to multiple lipid mole-
cules. Abstraction of a hydrogen by the peroxyl (or other) radical
group on the initially attacked lipid converts it to a non-radical spe-
cies, such as a hydroperoxide. Fig. 2 shows the major subgroups of
oxPL that are generated by radical attack mechanisms.
The ﬁnal step in lipid peroxidation is termination, which can be
achieved in 2 ways. Under conditions where the concentration of ini-
tiating radicals is sufﬁciently high to support radical–radical reactions
result in the formation of non-radical phospholipids products [27]. Al-
ternatively, termination may occur by the intervention of lipophilic
chain-breaking antioxidants such as β-carotene or α-tocopherol,
which have relatively stable conjugated radical forms [28].
The basic principles of the process of phospholipid peroxidation are
quite well established, and apply to phospholipid peroxidation both in
vitro and in vivo. Nevertheless, questions over somemechanistic details
remain, and while many fragmentation products of different native
phospholipids have been identiﬁed, it is quite possible that others are
yet to be discovered. The next sections discuss in more depth some as-
pects of the chemistry of phospholipid peroxidation. Much of this
knowledge has come from studies in carefully deﬁned synthetic sys-
tems such as liposomes, which limit the complexity of the products
and facilitate understanding of the mechanisms.
2.2. The diversity of oxidized phospholipid products from peroxidation
From the previous section it is clear that a diverse range of different
products of phospholipid peroxidation may arise from radical-based
peroxidation. For any individual phospholipid species, the proﬁle of
oxPL generated is inﬂuenced by the oxidant species, the type of linkage
of the FA to the glycerol backbone, and the fatty acyl chain present. The
position of the double bonds in an unsaturated FAwill in turn inﬂuence
the site where the oxidant species attacks. However, while in acyl
chains with only one bis-allylic hydrogen atom (e.g. linoleoyl) identiﬁ-
cation of the products and therefore the mechanism is a fairly simple
task, it becomes far more complicated in acyl chains with more bis-
allylic atoms (arachidonoyl, eicosapentanoyl and docosahexaenoyl),
owing to the number of possible sites of attack and secondary radical
reactions.
The diverse oxPL species that are formed from the initial carbon
and oxygen centred radical PL species can be divided into several sub-
classes, depending on themechanism bywhich they become stabilised
and therefore the structures of these ﬁnal products. Stabilisation of the
peroxyl radical by inter- or intra-molecular hydrogen abstraction re-
sults in formation of hydroperoxide derivatives, which may subse-
quently rearrange or be reduced to hydroxy-, keto- or epoxy-
containing species. Alternatively the peroxyl radical may carry out an
intramolecular attack leading to endoperoxide formation and subse-
quent cyclisation reactions to form compounds with substituted cyclo-
pentane or cyclopentene rings (isoprostanes and neuroprostanes). Gao
and colleagues have shown the formation of prostaglandins D2 and E2
via an isoprostane-like pathway that appeared to be cyclooxygenase-
independent and probably involved an epimerisation mechanism [29].
Isolevuglandins (also known as isoketals) are another subclass of com-
pounds formed following cyclisation of peroxyl radicals by cleavage of
the 5-membered ring [30]. All of these latter groups of compounds
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though not in a linear sequence, and therefore class as non-fragmented
oxPL.
In addition to these full chain length oxPLs, rearrangement of
alkoxyl radicals with carbon–carbon cleavages in turn generates a va-
riety of oxPL that contain a shortened fatty acyl chain. Depending on
the terminal group present, these can be grouped in various sub-
classes of oxPL, namely alkanals (saturated aldehydes), alkenals (un-
saturated aldehydes), hydroxy-alka(e)nals, alkanoates (saturated
carboxylic acids), and hydroxy-alkanoates [31]. Extreme chain-
shortened oxidized products can also be formed: for example, attack
by ozone or radicals on plasmenyl phospholipids results in formation
of 1-formyl-2-acyl-PL [32]. In addition, of course, different carbon
chain length alkanes, alkenes, aldehydes, carboxylic acids and hy-
droxides are released by this oxidation process, depending on the
native acyl chain and site of attack. The phospholipid fragmentation
products (secondary peroxidation products) formed with various oxi-
dant systems have been well characterized in linoleoyl [33,34], arachi-
donoyl [11,33,35–38] and docosahexaenoyl-containing phospholipids
[39]. Over time the relative abundance of fragmentation productsincreases, usually accompanied by the decrease in longer carbon chain
(intact) oxPL, and the structural diversity of the oxPL subclasses is grad-
ually decreased. It is important to note that some individual products
can result from several different unsaturated acyl chains, while others
are unique to a particular native fatty acyl chain (Table 2), thus acting
as a ﬁngerprint for the type of oxidation.
2.3. Other pathways of phospholipid oxidation
Unsaturated phospholipids are also susceptible to 2 electron, elec-
trophilic attack by certain non-radical oxidants, which leads to some
unique products (Fig. 2). For example, it is well-established that
myeloperoxidase-derived hypohalous acids oxidize fatty acyl chains at
the alkenyl double bonds, yielding halohydrins (α-halogenated β-
hydroxylated compounds), and more recently HOCl has been shown
to attack vinyl ether bonds in plasmalogens, resulting in degradation
of the phospholipid to α-chlorofatty aldehydes and lysolipids, which
can subsequently be modiﬁed further to chlorohydrins [40–42].
Nitrated lipids can be formed by multiple pathways following at-
tack of reactive nitrogen species derived from nitric oxide, including
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Table 2
Oxidized fragmented acyl chains formedby alkoxyl rearrangement in unsaturated fatty acids.
Lineloyl Arachidonoyl Docosahexaenoyl
8-Oxo-octanoyl 5-Oxo-pentanoyl 4-Oxo-butanoyl
8-Carboxy-octanoyl 5-Carboxy-pentanoyl 4-Carboxy-butanoyl
9-Oxo-nonanoyl 4-Keto-7-oxo-5-heptenoyl 4-Hydroxy-6-oxo-5-
hexenoyl
9-Carboxy-nonanoyl 4-Hydroxy-7-oxo-5-
heptenoyl
4-Keto-6-oxo-5-
hexenoyl
11-Oxo-9-undecenoyl 4-Keto-7-carboxy-5-
heptenoyl
4-Hydroxy-6-carboxy-
5-hexenoyl
9-Keto-12-oxo-10-
dodecenoyl
4-Hydroxy-7-carboxy-5-
heptenoyl
4-Keto-6-carboxy-5-
hexenoyl
9-Hydroxy-12-oxo-10-
dodecenoyl
8-Oxo-5-hydroxy-6-
octenoyl
4-Hydroxy-7-oxo-5-
heptenoyl
9-Hydroxy-12-carboxy-
dodecenoyl
8-Oxo-5-keto-octenoyl 4-Keto-7-oxo-5-
heptenoyl
9-Keto-12-carboxy-
dodecenoyl
8-Carboxy-5-keto-6-
octenoyl
4-Hydroxy-7-carboxy-
5-heptenoyl
13-Oxo-9,11-
tridecedienoyl
8-Carboxy-5-hydroxy-6-
octenoyl
4-Keto-7-carboxy-5-
heptenoyl
8-Keto-13-oxo-9,11-
tridecedienoyl
4-Keto-9-oxo-5,7-
nonedienoyl
8-Hydroxy-13-oxo-9,11-
tridecedienoyl
5,10-Dihydroxy-11-oxo-6,8-
undecedienoyl
10-Hydroxy-13-oxo-5,8,11-
tridecetrienoyl
2378 A. Reis, C.M. Spickett / Biochimica et Biophysica Acta 1818 (2012) 2374–2387peroxynitrite, nitrogen dioxide and nitrous oxide [43,44]. These forms
of attack are mainly one-electron reactions and can be classed as ox-
idation reactions, but they generate a different product proﬁle to the
lipid peroxidation reaction described above, instead forming nitration
speciﬁc products such as β-nitroalkyl radicals, nitroalkenes, nitro-
nitrile esters and nitrohydroxy species. Hydrogen abstraction can
also occur, leading to the same fragmented peroxidation products
that are observed after attack by oxygen radical species [44]. Nitrated
fatty acids are now known to show bioactivity and have pathological
relevance; for further detail the reader is referred to other publica-
tions in this area [44,45].
3. Factors affecting oxidized phospholipid formation
Much of the information to date on the chemical mechanisms of
phospholipid oxidation comes from studies of aqueous preparations
of phospholipids, such as liposomes or multilamellar vesicles, used
as simple models of biological membranes. While the ultimate goal
is to understand how oxidants affect biological membranes, valuable
information can be obtained from analysis of systems containing a
limited number of lipid species, in order to determine the intermedi-
ates and products of individual phospholipids. Liposomes are com-
monly prepared from one or a small number of phospholipids,
where the phospholipid of interest usually has heterogeneous fatty
acyl compositionwith a 1-acyl saturated chain and a 2-acyl unsaturated
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studies conducted on the formation, identiﬁcation and quantiﬁcation
of oxidized phospholipids have been focused on the choline class of
phospholipids, as they comprise nearly 50% of total PL in biological
membranes [46], and are thus important molecules. Being more abun-
dant, they are alsomore readily available commercially in pure form. Fi-
nally, they are the phospholipids most easily detected by positive ion
electrospray mass spectrometry, a frequently used analytical technique
for studying their oxidation.
3.1. Inﬂuence of liposome size and composition
It is important to bear in mind that the type of liposome prepara-
tion used may inﬂuence the oxidation process. Firstly, multilamellar
vesicles (MLVs; formed during sonication) can be expected to have
different kinetics to unilamellar vesicles, or liposomes (formed by ex-
trusion of MLVs through polycarbonate ﬁlters), in view of the differ-
ent accessibility of the phospholipid layers to aqueous oxidants.
Secondly, a small number of studies have reported differences in ox-
idative susceptibility of liposomes of the same phospholipid composi-
tion but different sizes, which can be generated using different pore
sizes and extrusion pressures. Small unilamellar vesicles (SUVs) pre-
pared from phosphatidylcholines were found to undergo more oxida-
tion than large unilamellar vesicles (LUVs), assessed by measurement
of conjugated dienes, trienes, and thiobarbituric acid reactive sub-
stances [47]. Similar results were obtained in another study that com-
pared small sonicated liposomes and large non-sonicated liposomes
prepared from retinal lipids and oxidized with Fe2+ and Fe3+ as radical
initiators, and showed longer lag times in the larger liposomes [48]. In
both cases, it was hypothesized that the greater oxidation of SUVs was
due to higher surface curvature and more openly packed headgroups
compared to LUVs, which enabled greater penetration of water soluble
radicals and consequently oxidation. The occurrence of asymmetric oxi-
dation of phospholipids in the inner and outer leaﬂets of giant unilamel-
lar vesicles has also been shown [49]. The situation is further complicated
in vivo by the fact that different fatty acid chains esteriﬁed to the glycerol
can also inﬂuence the acyl packing and bilayer curvature. These results
may explain the variability in phospholipid oxidation observed in vitro
between different studies with apparently comparable conditions, as li-
posome size is a parameter that is commonly overlooked. Thus it is im-
portant to normalize liposome sizes for truly comparable results [50].
3.2. Inﬂuence of the oxidant system
There are many reports in the literature of phospholipid peroxida-
tion, carried out on a wide variety of phospholipid starting material
and with an equally broad range of oxidizing systems. The most fre-
quently studied methods of causing chemical radical reactions are
metal-catalysed reactions (generating •OH), autoxidation, radiation
(generating •OH and 1O2) and ozone (O3); popular enzymatic radical
generating systems include lipoxygenases and myeloperoxidase. The
phospholipids that have been mostly studied in liposome models are
those containing an arachidonoyl chain, as these are readily oxidizable.
Table 3 compares the oxidized products identiﬁed for arachidonoyl-
based PC using different chemical and enzymatic oxidants in studies
of unilamellar model systems at 37 °C (liquid crystalline phase). The
concentrations of oxidants and the lengths of the oxidation reaction
are indicated, together with the analytical techniques employed, as
these have a direct inﬂuence on the oxidation products observed.
It can be seen that the oxidized products identiﬁed depend on the
oxidant system, concentration and the length of the incubation used.
As a generalization, modiﬁcation by chemical oxidants leads to the for-
mation of a wider variety of oxidized products compared to those de-
scribed for enzymatic systems, which tend to yield speciﬁc products.
However, some common features can also be found for the chemical
radical generating systems, and much of the reported variability relatesto modiﬁcations around C-5 position of arachidonoyl chain. Lysolipid
species with either the saturated or unsaturated acyl chain remaining
have also been reported [40,51], both following free radical attack and
oxidation with hypohalous acids (e.g. HOCl and HOBr) [52], although
it is more common for the oxidized chain to be lost and the saturated
acyl chain to remain esteriﬁed to the headgroup. This involves an intra-
molecular reaction initiated by reactive moieties in the oxidized chain,
and a mechanism for several different full chain oxidation products
has recently been reported [53], demonstrating that the oxidized
chain is lost by spontaneous formation of a lactone. The oxidant also
makes a difference to the products of plasmenyl phospholipids: radical
oxidations and attack by ozone result in the formation of 1-formyl-2-
acyl-PL with cleavage of an n-1 alkenal moiety [32,54]. In contrast, at-
tack at the vinyl ether by myeloperoxidase-generated oxidants leads
to formation of a lysolipid plus a 2-halofatty aldehyde [41]. These cleav-
age reactions reﬂect the fact that the vinyl ether is more susceptible to
chemical attack than the ester bond [55], and also that beyond the
vinyl ether bond the chains are commonly saturated, while polysatu-
rated chains are usually linked by ester bonds to the glycerol backbone,
so the site of likely attack is different.
3.3. Selectivity of modiﬁcation dependent on fatty acyl chain
As seen in the previous sections, oxidative damage to phospho-
lipids results in a wide variety of different products, depending on
the initiating agent responsible and the phospholipid under attack.
The free radical or oxidative modiﬁcations carried out directly by en-
zymes as a general rule produce speciﬁc modiﬁcations, at least at the
primary product stage, with a moiety such as a hydroperoxide or hy-
droxide introduced at a speciﬁc location in the fatty acyl chain. A good
example of this is offered by cyclooxygenases (COX) and the lipoxy-
genase (LOX) family: several lipoxygenases from different biological
sources catalyse the formation of positional isomers of hydroperox-
yeicosatetraenoic acid, e.g. 5-LOX and 12/15-LOX [56–58]. On the
other hand, non-enzymatic oxidative damage by free radicals is usu-
ally considered to lack the speciﬁcity of enzymes, as attack by free
radicals can theoretically take place at any of the carbon atoms con-
taining bis-allylic hydrogen atoms to yield a larger variety of position-
al isomers. Surprisingly, accumulated experimental observations by
different research groups have shown that arachidonoyl-containing
phospholipids tend to form oxidation products with low carbon
chain lengths with the predominance of modiﬁcations at either C-5
or C-8 (Table 3). Modiﬁcations resulting from attack at the C-10 and
C-13 bis-allylic hydrogen atoms are less common. Currently, it is not
clear whether this is because hydrogen atoms closer to the polar
head are more likely to be abstracted, or that longer chain hydroper-
oxide derivatives are less stable and fragment preferentially to these
products. Possible mechanisms and evidence for the former possibil-
ity were discussed in Section 3.1 on the effect of liposome size; evi-
dence for the second suggestion is discussed in Section 4. In view of
the evidence that bilayer curvature affects the accessibility of the
fatty acyl chains to oxidants, it would be interesting to know whether
the location of the attack is also dependent on liposome size.
Many of the products of arachidonoyl-containing PC species with
different oxidants have also been observed for the arachidonoyl-
containing phosphatidylethanolamines [38] and phosphatidylserines
[59]. This suggests that differences in the hydration layer at the
polar group head between these species do not substantially inﬂu-
ence the accessibility of the fatty acyl chains to oxidants, and there-
fore have little effect on the oxidized products formed.
4. Recent advances in understanding of phospholipid oxidation
mechanisms
Despite the extensive knowledge already achieved on the reac-
tions leading to formation of peroxyl, alkane, alkene and aldehyde
Table 3
Dependence of phospholipid oxidation products on the oxidant system employed.
Oxidant system Oxidation products identiﬁed Detection Reference
Chemical
oxidants
Cu (II)/H2O2, 3 h Hydroxy (C-5); di-hydroxy (C-5, C-12) QQQ [54]
Fe(II)/H2O2 POVPC, PGPC, 8-oxo-5-hydroxy-octenoylPC,
4-keto-nonadienoylPC, 13-oxo-10-hydroxy-tridecenoylPC,
palmitoyl-(hydroxy-A)PC, palmitoyl-(hydroperoxide-A)-PC,
PEIPC, palmitoyl-lysoPC, arachidonoyl-lysoPC
Reverse-phase LC-MS (Q-TOF) [37]
Autoxidation (48 h) POVPC, PGPC, PEIPC, ions up to addition of 9
oxygen atoms are visible in the MS spectrum
QQQ [11]
Autoxidation (24 h) +3 oxygen atoms (m/z 830), + 4 oxygen atoms (m/z 846) Sector instrument (FAB-MS) [107]
AAPH (2 mM), 3 h 5-Keto, 8,9-epoxy, 5,6-epoxy, 11,12-epoxy, 5,6-di-hydroxy QQQ [54]
AAPH (10 mM) 5-HETE, 8-HETE, 9-HETE, 11-HETE, 5,6-ETE, 8,9-ETE, 5,
12-di-hydroxy, 1 formyl-APC, POVPC, lyso-PC
QQQ [35]
AAPH 5-OH, 15-OH (where 5-OH>>15-OH) [108]
AAPH (80 mM) 1-Acyl-2-(5-oxo-pentanoyl)-PC HPLC-ﬂuorescence (DBD-H derivatives) [106]
t-BHP (140 mM) Mono-OOH, di-OOH VG platform [109]
HOCl/OCl (13 mM), 20 min–1 h Monochlorohydrins, bis-chlorohydrins,
stearoyl-lyso-PC, SOVPC, SGPC
MALDI [42]
UVA, 80 Jcm−2 Mono-OOH (m/z 814), bis-OOH (m/z 846),
tri-OOH (m/z 878), PEIPC (m/z 828),
NO lyso-PC, NO fragmented-PC
QQQ [110]
UVB, 400 Jm2 1-Hexadecyl-2-(4-butanoyl)-PC QTrap [111]
Enzymatic
oxidants
MPO-H2O2―Cl Mono-chlorohydrins, di-chlorohydrins,
tri-chlorohydrins, tetra-chlorohydrins,
Lyso-PC (saturated), no fragmented PC
MALDI [112]
MPO Mono-chlorohydrins, di-chlorohydrins,
tri-chlorohydrins, tetra-chlorohydrins,
Lyso-PC (saturated), no fragmented PC
MALDI [52]
MPO-H2O2―NO2 8-Carboxy-5-OH-octenoylPC (HOdiA-PC),
8-carboxy-5-keto-octenoylPC (KOdiA-PC),
8-oxo-5-OH-octenoyl-PC (HOOA-PC),
8-oxo-5-keto-octenoylPC (KOOA-PC)
QQQ [33]
LOX (reticulocyte, rabbit) 15(S)-OOH-arachidonoyl-PC HPLC-UV-MS [113]
LOX (reticulocyte, rabbit) 15-OOH-arachidonoylPC GC–MS [56]
LOX (reticulocyte, rabbit) 15(S)-OOH-arachidonoyl HPLC-UV [56]
LOX (porcine) 12(S)-OOH-arachidonoyl-PC HPLC-UV-MS [113]
LOX (reticulocyte, rabbit) 15-OOH-arachidonoylPC HPLC-CEC [57]
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outstanding aspects of the lipid peroxidation process remaining to
unravelled. For instance, fatty acid chains in vivo exhibit a cis geome-
try, though this geometry is lost after attack by radicals [60], but so far
relatively little attention has been devoted to the presence of trans
fatty acids in biological membranes and understanding of their bio-
logical relevance remains scarce [61].
Another example relates to the mechanism underlying the forma-
tion of HNE and its derivatives from ω-6 fatty acids, which has been
extensively studied. The most accepted mechanism involves the 4-
hydroperoxy-nonenal intermediate arising from both linoleic acid
(13-HPODE) and arachidonic acid (15-HPODE) by alkoxyl rearrange-
ment with bond cleavage [62,63], although an alternative mechanism
involving cross-chain peroxyl addition followed by decomposition
has been suggested for lineloyl chains from cardiolipin phospholipids
[64]. However, the question about what factors govern the routes of
alkoxyl rearrangement and carbon–carbon chain cleavage to form un-
saturated aldehydes (Fig. 3) still remains unsolved in the literature.
Taking into consideration the literature on the formation of HNE
through the decomposition of puriﬁed hydroperoxide derivatives
[62,63], it seems that the most likely route for decomposition of inter-
mediate oxidation products (alkoxyl species) is via the formation of
aldehydes of low carbon chain length [50].
Although phospholipids can be assembled with various polyunsatu-
rated fatty acyl chains, some ofwhich contain several bis-allylic hydrogen
atoms that are all theoretically equally likely to be abstracted during
radical initiation step, experimental data over the years has shown a
predominance of secondary products with C9 carbon chains (oxo-
nonanoyl) for lineloyl, C5 (oxo-valeroyl) for arachidonoyl, and C4
(oxo-butyroyl) for docosahexaenoyl chains. This is almost a ﬁnger-
print of the unsaturated fatty acyl chains that have undergoneoxidation. Whether the consistence observed is the result of greater
stability of these saturated secondary products or preferential attack
on the bis-allylic hydrogen atoms closer to the polar head is not yet
fully understood. Arguments in favour of the ﬁrst hypothesis have
been proposed by Balamraju et al.; they suggested that the γ-
hydroxy-α,β-unsaturated aldehydes formed during radical oxida-
tion degrade via a Michael addition of a peracyl radical with forma-
tion of a β-hydroxyperester, with concomitant loss of a 3 carbon
chain resulting in the formation with accumulation of saturated al-
dehydes (Fig. 4) [65]. Also, γ-hydroxy-alkenals can be involved in
an alternative mechanism with cyclisation to a hemiacetal interme-
diate followed by dehydration and conversion to furan [66].
This hypothesis is supported by the observation of longer carbon
chain secondary products in the initial stages of peroxidation and
their decrease over time and concomitant increase of shorter carbon
chain length compounds. Further corroboration comes from spin
trapping experiments conducted on the identiﬁcation of phospholip-
id and lipid radical species (intermediate peroxidation species),
where linoleoyl- and arachidonoyl-containing phospholipid radical
species were located at C-11, C-13 and C-14 positions [67–69]. The
identiﬁcation of unstable and highly reactive radical species is possi-
ble through the stabilisation of the unpaired electron by reacting
with a paramagnetic spin trap. The spin trap stabilises the radical
(in the form of radical adducts) enabling their accumulation in solu-
tion to detectable levels. Detection is usually conducted by electron
paramagnetic resonance (EPR) or mass spectrometry (MS). Stabilisa-
tion of radicals by the spin trap also enables the radical to be tagged,
allowing information about the exact nature and location of the rad-
ical within the unsaturated acyl chain to be obtained. Spin trapping
experiments conducted on oxidized linoleic acid by the Fenton reac-
tion showed a higher relative abundance of smaller carbon chain
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Similarly, the identiﬁcation of smaller alkyl (L•) DMPO radical adducts
and the absence of longer alkyl DMPO adducts suggests that β-
scission occurs with release of smaller carbon chain alkyl radicals
[70]. The formation of smaller alkoxyl radicals at positions distant
from the polar head with concomitant formation of longer carbon
chain aldehydes and small alkyl radicals is consistent with random at-
tack by free radicals at the various bis-allylic positions [50]. The longer
carbon chain aldehydes formed may undergo further decomposition
to more stable saturated aldehydes, in agreement with the ﬁndings de-
scribed previously [65]. On the other hand, support for the concept that
attack closer to the headgroup is favoured comes from the observation
that smaller liposomes with higher curvature are more susceptible to
oxidation [47,48], as described in Section 3.1.Whatever themechanism
responsible for this effect, this “speciﬁcity” is well-known, and almost
resembles that found during enzymatic oxidative attack [56–58],
which may also account for the fact that secondary oxPL such as alka-
nals and alkanoates are predominantly detected in biological samples
[12,13,38].
5. Analysis and quantiﬁcation of oxidized phospholipids
The analysis of the complete family of phospholipid oxidation prod-
ucts is challenging because of the diversity and extent of the products,
as described above, and no singlemethod exists that enables quantiﬁca-
tion of all known oxPL products from the various subclasses. Somewell
established methods are simple to perform, but may lack speciﬁcity or
be limited in the products observed [71]. Reliable and accuratemethods
have been developed for the quantiﬁcation of primary PL products (hy-
droperoxides) by chemiluminescence methods that allow the quantiﬁ-
cation of PLOOH up to pmol level [72–74] and for fragmented oxPL(containing terminal carbonyl groups) by use of dinitrophenylhydra-
zine (DNPH) post-column derivatisation followed by detection at
λ=340–380 nm (UV range) enabling quantiﬁcation up to μM [75].
While the non-esteriﬁed breakdown products of oxidized phospho-
lipids are relatively volatile and can be detected readily using GC–MS,
this method cannot be applied directly to oxidized phospholipids [71].
Instead, the most widely used method is electrospray ionisation MS,
as this is not dependent on analyte volatility.
5.1. Mass spectrometry in the study of oxPL
Currently, mass spectrometry coupled with liquid-chromatography
is the best choice for the detection of a wide range of oxPL; it can offer
qualitative and quantitative information about both primary and
secondary phospholipid oxidation products and lyso-PL without
the need for derivatisation procedures, while showing good linearity
and reproducibility across a wide range of concentrations. The levels
of oxPL reported in literature in model membranes vary widely as
they depend on the extent of oxidation reaction at the time point
at which they were acquired. Moreover, there are a number of im-
portant factors that affect the observation of analytes and complicate
its application in biological samples.
One potentially problematic aspect of mass spectrometry as a de-
tection technique for oxPL is that it relies largely on the ionisation ef-
ﬁciency of molecules in the gas-phase; differences in this efﬁciency
especially between PL classes can lead to ion suppression effects,
resulting in spectrum with poor signals or even absence of PL classes
with lower ionisation efﬁciencies. Speciﬁcally, the ionisation process
of phosphatidylcholines (PC) during mass spectrometry analysis is fa-
cilitated by the fact that they are naturally positively charged mole-
cules (trimethylamine group located at the polar head), and this
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pression can also result from even relatively low concentrations of
salts in the samples. These factors are exacerbated when analysing bi-
ological samples by shotgun lipidomics approaches, but can be over-
come by interfacing with LC to remove salts and abundant
unmodiﬁed species. Through this approach, identiﬁcation of oxPC
can be achieved based on the m/z value, the retention time and the
fragmentation pattern, narrowing the likelihood of misinterpretation
of isobaric oxPC species present in complex mixtures. The carbon
chain length, size of the analyte, and degree of unsaturation further
inﬂuence the detection of oxPL [77]; the preferential ionisation of
lower molecular weight oxPC results in mass discrimination effects,
thus presenting a challenge in handling the diversity of oxPC prod-
ucts. Moreover, differences in the chemical stability of relatively less
stable (e.g. carbonyl) and thermally labile chemical groups (e.g. hy-
droperoxides) may lead to apparent differences in the relative abun-
dances observed, which is crucial for accurate quantiﬁcation. Finally,
quantiﬁcation depends on having internal standards, preferably iso-
topically labelled versions of the analyte to give speciﬁc mass shifts,
but the phospholipids available as internal standards are limited
and only cover a small part of the necessary mass range.
Despite the limitations described, the ability of mass spectrometry
to detect a wide range of compounds with high sensitivity has made
this technique popular for use in both model and biological samples,
and offers the beneﬁt of obtaining information at a molecular level.
The limit of quantiﬁcation of oxPCs by mass spectrometry is similar
to that reported for alternative chemiluminescence methods (pmol;
μM range) [78], but can be lowered to femtomole levels through the
use of complimentary enrichment methodologies, with the additional
advantage of obtaining structural information by tandem mass
spectrometry.5.2. 31P NMR in the study of oxPL
In many ways, nuclear magnetic resonance spectroscopy (NMR) is
complementary to mass spectrometry in terms of its advantages and
limitations. It is intrinsically a quantitative technique, whereby the
intensity of the signal in the spectrum correlates linearly to the
amount present in the sample, assuming appropriate pulse sequences
and settings for parameters such as relaxation time are employed. It is
less affected by salt concentrations (so long as paramagnetic metal
ions are removed). Phospholipids can be conveniently detected
using 1H-, 13C- or 31P-NMR, of which 1H is most sensitive and 13C
least sensitive, in part owing to a natural abundance of only 1%. How-
ever, 13C-NMR is usually carried out with C―H uncoupling to im-
prove sensitivity and simplify the spectra, and under these
conditions the quantitative relationship is lost. 31P-NMR has an ad-
vantage for analysis of phospholipids, as these are detected selective-
ly over non-phosphorus containing lipids, and 31P has almost 100%
natural abundance so strong signals are obtained. In phospholipids
there is no signiﬁcant splitting of the phosphorus signals due to cou-
pling, and clearly resolved peaks can be observed; this is in contrast
with 1H NMR where overlapping signals and complex coupling pat-
terns complicate the quantiﬁcation of the signals even with modern
high ﬁeld strength instruments such as 800 MHz spectrometers
[79]. Both 1H and 31P-NMR have been used in studies of phospho-
lipids in vitro and analyses of biological lipid extracts, as they can dis-
criminate between saturated, unsaturated and alkylacyl and
alkenylacyl species for choline phospholipids and also between PL
classes [80–83]. However, to date very few studies have used these
approaches to investigate phospholipid oxidation and for the analysis
of oxidized phospholipids. The formation of lysophosphatidylcholines
following attack by hypochlorous acid on PC multilamellar liposomes
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been observed using phosphorus NMR. The appearance of hydroper-
oxides and conjugated double bonds in model liposomes subjected
to enzymatic peroxidation was detected by 1H-NMR, although these
products could not be detected in extracts of rat liver mitochondria
under oxidative stress [85]. In addition to this, the oxidation product
1-palmitoyl-2-(15-hydroperoxide-arachidonoyl)-PC was detected
after incubation of PC with soybean lipoxygenase, using 31P-NMR
with an improved solvent system that prevented aggregation [80].
The small number of studies using NMR probably reﬂects the limita-
tions of the technique, which include lower sensitivity compared to
MS, and for 1H-NMR of complex mixtures, multiple overlapping reso-
nances from similar molecules that complicate identiﬁcation of minor
species such as oxPL. However, the manufacture of spectrometers
with higher ﬁeld strengths and methodologies developed for metabo-
lomics are steadily improving sensitivity and selectivity, and it is pos-
sible that in the future that this technique will become more useful
for proﬁling of oxPL in biological samples.
6. Detection and quantiﬁcation of oxPL in biological systems
There is considerable interest in identifying and quantifying oxi-
dized phospholipids in biological samples, as it is increasingly clear
that they are produced in a wide variety of inﬂammatory situations,
and play a role in changes in cell behaviour during pathology
[86,87]. The wide variety of oxPLs complicates the acquisition of com-
prehensive knowledge about the formation of oxPL in biological sam-
ples, and moreover several factors may complicate the detection and
quantiﬁcation of oxPL in biological samples, as described below. It is
also important to bear in mind that oxidized phospholipids may not
be homogenously distributed within cells or tissues with polyunsatu-
rated PL in colocalised areas, but during most extraction protocols in-
formation on subcellular location is lost. The levels of individual
species of oxPL are often very low as a percentage of unmodiﬁed phos-
pholipids, which owing to ion suppression increases the difﬁculty of
analysing them by mass spectrometry, unless efﬁcient separation
methods are used.
6.1. Detection of oxPL may be complicated by issues of stability and
metabolism
In attempting to quantify oxPL in biological samples and relate
these to the extent of oxidation damage and lipid peroxidation, it is
important to bear in mind that some products of lipid peroxidation
are inherently chemically unstable, particularly the radical species
formed in the initial stages of the process, and to a lesser extent, the
hydroperoxides that result from the propagation step. The latter can
be metabolized by enzymatic systems in vivo, such as phospholipid-
dependent glutathione peroxidase (PhGPx), thioredoxin or other sele-
noproteins; these reduce phospholipid hydroperoxides to hydroxy de-
rivatives, thus lowering the concentration of primary oxPL products
and increasing the concentration of more stable end products [1]. Fur-
ther downstream in the process, the oxPL containing carbonyl groups
formed by fragmentations may react with proteins in the local environ-
ment, especially integral membrane proteins, to form adducts, thus
lowering the concentration of free secondary oxPL products.
Carbonyl-containing products react readily with amines, and can at-
tack lysine residues to form Schiff's bases; α,β-unsaturated prod-
ucts, such as phospholipids containing a hydroxyalkenal moiety,
can also react with histidine, cysteine and lysine residues by Michael
addition to form protein-LPO adducts, and owing to the aldehyde
group these have the potential to cross-link proteins [71]. In addition
to this, the ﬁndings that oxPL activates phospholipase A2 were recently
reported [88], and may also inﬂuence the concentration of secondary
oxPL to very low levels in vivo with concomitant increase of lysolipidsand free aldehydic products. The importance of these reactions will be
discussed in more detail in other articles in this issue.
6.2. Quantiﬁcation of oxPL in cells and tissues
As described above, oxidized phospholipid products can be
detected mostly conveniently by electrospray mass spectrometry
coupled to reverse phase HPLC, and a substantial number of studies
have used this approach to observe the presence of oxidized PL in
cells and tissue from a variety of oxidative conditions, and demon-
strate increased levels compared to controls. Many of the data pub-
lished on the analysis of phospholipids in biological samples focus
on particular PL classes, especially PC as it is one of the most abundant
phospholipids and its high ionisation efﬁciency facilitates its detec-
tion, as mentioned in Section 5.1. For example, hydroxylated PCs
were detected at increased levels in plasma samples from breast can-
cer patients, and suggested as potential biomarkers based on more
signiﬁcant changes than other PL classes [89]. SAPC-HETEs were ob-
served in liver of CCl4-treated rats [90], while POVPC, PGPC, PEIPC
and PC hydroxyalkenals were observed in extracts of human athero-
sclerotic lesions [91,92], but the amounts were not reported. Nakanishi
et al. reported increased levels of several oxidized PCs in ischaemic
mouse myocardium compared to non-ischaemic tissue, with the data
reported as counts/mg tissue [93]. Increases of approximately 10–15-
fold have been reported for POVPC, PGPC, PEIPC and PECPC as well as
lyso-lipids in cholesterol-fed zebraﬁsh compared to the ones on the
control diet [94].
The quantiﬁcation of oxPL in biological systems is challenging and
depending on the types of biological sample studied, the levels of ox-
idized PL analysed are quoted in a variety of different ways, which
complicates the comparison of concentrations between studies. In
studies of human monocytes and platelets activated by a calcium ion-
ophore or thrombin respectively, levels of HETE-PC were reported as
18 ng/4×107 platelets and HETE-PE were 6 ng/4×107 platelets and
150 ng/4×106 monocytes [95]. Another group has studied the forma-
tion of hydroperoxides of several PL classes in the small intestine of
mice following total body γ-irradiation, and found levels of
20–60 mmol/mol parent lipid in treated animals compared to
4–7 mmol/mol in un-irradiated animals [59]; interestingly, the levels
of CL and PS increased approximately 10-fold, muchmore than the 3–
4-fold observed with more abundant PLs PE and PC. This interesting
headgroup selectivity probably represents a biological process involv-
ing a speciﬁc interaction of cytochrome c with the anionic phospho-
lipids [96]. The same group also measured rat cortical neurones,
sheep lung endothelial cells and mouse lung tissue under conditions
that led to apoptosis, and levels of cardiolipin hydroperoxides varying
from 1 to 100 pmol/nmol CL and levels of PS hydroperoxides in the
range 3–25 pmol/nmol PS were observed; thus between 0.1 and
10% of the parent lipid was oxidized under these conditions [97].
There have been few studies of atherosclerotic plaque material both
from humans patients and from high-fat diet fed animals, which
have also reported high levels and signiﬁcant increases in oxidized
PLs. Watson et al. measured the levels of PGPC, POVPC and PEIPC in
the aorta of rabbits on an atherogenic diet in the range of 40–65 ng/
mg wet tissue, representing a 2–3-fold increase over control tissue
[11]; while in another study even higher concentrations (50–100 μg/g
wet tissue) weremeasured for the same oxidized PLs and their stearoyl
analogues [98]. PC core aldehydes POVPC, SOVPC, PONPC, SONPC and
HNE-PCwere detected inmaterial from human atherosclerotic plaques,
although by far the most abundant component was POVPC at a concen-
tration of 20–40 μg/g tissue depending on the plaque type; levels of the
other aldehydes were in the range 1–8 μg/g tissue [13]. By contrast,
analysis of human or animal plasma samples has indicated rather
lower levels of fragmented oxidized PCs, with concentrations ranging
from approximately 0.5–6 μM in disease or inﬂammatory conditions,
corresponding to 2 to 10-fold increases relative to control samples
2384 A. Reis, C.M. Spickett / Biochimica et Biophysica Acta 1818 (2012) 2374–2387[99,100]. However, the ratio of full chain oxidized and fragmented PCs
to total PC measured in another study was 0.1–2% [101], which is com-
parable to the ratios found in some inﬂammatory tissue samples men-
tioned above.
There are relatively few reports on quantitative analysis of
nitrated and chlorinated PLs in vivo. Several studies have reported
on the plasma levels of nitrated fatty acids in free and esteriﬁed
forms, but there is some disagreement in the literature. An early
study reported 0.2 μM and 0.5 μM total esteriﬁed nitro-linoleate iso-
mers in red blood cells and plasma from healthy humans respectively
[102], and subsequently slightly lower esteriﬁed nitro-oleate concen-
trations of 0.15 μM and 0.3 μMwere measured [103]. However, a later
study reported much lower (~1 nM) levels of the free nitrated fatty
acids using GC–MSMS, although the esteriﬁed forms were not mea-
sured [104]. However, it is thought that PL-esteriﬁed forms of nitrated
fatty acids occur at comparable levels to the free nitrated fatty acids
[105], and increased levels of both are expected under pathological
conditions. The presence of C16:0 and C18:0 lysoPC chlorohydrins
has been detected in human atherosclerotic lesions, and showed 69-
fold and 82-fold increases respectively compared to normal aorta, al-
though the absolute levels of these compounds were not determined
[40].
Thus in studies published so far there is considerable variability
in the levels of oxPL reported in physiological conditions, and the
majority of published reports have analysed carbonyl and carboxyl
fragmentation products of oxidized PC, although some studies
have also investigated full length oxidized products and other PL
classes. Possible explanations for the variability of biological con-
centrations of oxidized phospholipids include the different method-
ologies used for extraction of phospholipid from the tissues as well
as the different analytical approaches (direct infusion or MS inter-
faced to LC) and the instrumentation employed by the researchers.
More rigorous analytical studies are needed to begin to establish trust-
worthy concentration ranges for oxidized phospholipids in different
physiological and pathological conditions. Overall it is clear that the
quantiﬁcation of oxPL in biological systems is challenging, and the
amount of oxidized PL in disease states and in healthy conditions re-
mains subject of debate.
7. Conclusions and future perspectives
There is clearly undiminished interest in the ﬁeld of phospholipid
oxidation, both in terms of completing our understanding of the
mechanisms of formation of the wide gamut of products known and
elucidating their biological effects. Advanced analytical techniques,
especially electrospray mass spectrometry with fragmentation
protocols, have contributed enormously to the determination of
reaction pathways in model systems and detection of oxidized
phospholipids in biological samples. Nevertheless, our knowledge
about the location and concentrations of these compounds in
physiological and pathological situations is still rather limited.
A fuller understanding of the mechanisms of phospholipid oxida-
tion and the resulting products would allow proﬁling of physiological
and pathological conditions. Apart from yielding information on types
of oxidants responsible, and therefore their roles in pathology, this
could enable a “ﬁngerprinting” approach to oxidized phospholipids
as biomarkers of inﬂammation and injury. Potentially, this opens
the door to a systems biology approach to oxidative lipidomics,
which would allow theories of their formation and metabolism to
be tested. However, this will require improved methods of analysis
and better (or more widely available) standards. The recent develop-
ment of high resolution MS instruments with fast scan speeds and
polarity switching (i.e. Orbitrap instruments) that are suitable for
the screening of both positively and negatively charged compounds
in complex mixtures, will facilitate complete lipidome mapping of
biological ﬂuids and tissues. Combined with the development ofﬂuorescent probes for subcellular localization of oxidized phospho-
lipids, this should provide novel insights into the biology of these
compounds.
The interactions of oxidized phospholipids with proteins, either
involving the formation of adducts by reactive carbonyl groups from
fragmented oxPL or noncovalent interactions with receptors are
clearly important and need to be explored further. As the phospho-
lipid types most susceptible to attack and the reactive products
formed from them are elucidated, this knowledge can be used to
implement targeted mass spectrometry-based identiﬁcation of ad-
ducts formed between oxidized phospholipids and proteins. These
topics are the subject of further, more detailed reviews in this
issue.
Abbreviations and deﬁnitions
AAPH 2,2′-azobis(2-amidinopropane) dihydrochloride
Cer ceramide
CL cardiolipin
DNPH dinitrophenylhydrazine
FA fatty acid
LUV large unilamellar vesicles
L• alkyl lipid radical
OL• epoxy-alkyl lipid radical
LOO• peroxyl lipid radical
LO• alkoxyl lipid radical
OLOO• epoxy-peroxyl lipid radical
HOL• hydroxy-alkyl lipid radical
MALDI Matrix-assisted Laser Desorption Ionisation
MLV multi-lamellar vesicles
MPO myeloperoxidase
oxPL oxidized phospholipid
PC phosphatidylcholines lipids
PE phosphatidylethanolamine lipids
PS phosphatidylserine lipids
PAPC 1-palmitoyl-2-arachidonoyl-phosphatidylcholine
PDPC 1-palmitoyl-2-docohexaenoyl-phosphatidylcholine
PGPC 1-palmitoyl-2-glutaroyl-phosphatidylcholine
PL phospholipid
PLPC 1-palmitoyl-2-lineloyl-phosphatidylcholine
PLOOH phospholipid hydroperoxides
PONPC 1-palmitoyl-2-(oxo-nonanoyl)-phosphatidylcholine
POVPC 1-palmitoyl-2-(oxo-valeroyl)-phosphatidylcholine
PhGPx phospholipid hydroperoxide glutathione peroxidase
ROS reactive oxygen species
RA relative abundance
SM sphingomyelins
SUV small unilamellar vesicles
TAG triacylglycerides
DMPO 5,5′-dimethyl-1-pyrrolidine-N-oxide
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